Recent concepts in the management of male infertility

International Journal of Urology

Volumn 3, Issue 4, 1996, Pages 249-255

  Namiki, Mikio ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

Azoospermia; Male infertility; Spermatogenesis

Indexed keywords

CHORIONIC GONADOTROPIN; HUMAN MENOPAUSAL GONADOTROPIN;

AZOOSPERMIA; EJACULATION; HORMONAL THERAPY; HUMAN; MALE; MALE INFERTILITY; PRIORITY JOURNAL; REVIEW; SPERMATOGENESIS; VARICOCELE;

EID: 0029789081     PISSN: 09198172     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1442-2042.1996.tb00529.x     Document Type: Review

References (104)

1. Howard SS. Treatment of male infertility. N Engl J Med 1995;332:312-317.
2. Diedrich K, Felberbaum R, Kupker W, Al-Hasani S. New approaches to make infertility: IVF and microinjection. Int J Androl 1995;18(suppl):78-80.
3. Yovich J, Matson PL. Male subfertility: concepts in 1995. Hum Reprod 1995;10(suppl):3-9.
4. Michelmann HW. Minimal criteria of sperm quality for insemination and IVF therapy. Int J Androl 1995; 18(suppl):81-87.
5. Steptoe PC, Edwards RG. Birth after re-implantation of a human embryo. Lancet 1978;2:366.
6. BongsoTA, Ng SC, Mok H, Lim MN,Teo HL, Wong PC, Ratnam SS. Effect of sperm motility on human in vitro fertilization. Arch Androl 1989;22:185-190.
7. Rizk B, Doyle P, Tan SL, Rainsbury P, Betts J, Brinsden P, Edwards RG. Perinatal outcome and congenital malformations in in-vitro fertilization babies from the Bourn-Hallam group. Hum Reprod 1991; 6:1259-1264.
8. Palermo G, Joris H, Devroey P, Van Steirteghem AC. Pregnancies after intracytoplasmic injection of single spermatozoon into an oocyte. Lancet 1992;340:17-18.
9. Van Steirteghem AC, Liu J, Joris H, Nagy Z, Janssenswillen C, Tournaye H, Derde MP, Van Assche E, Devroey P. Higher success rate by intracytoplasmic sperm injection than by subzonal insemination. A report of a second series of 300 consecutive treatment cycles. Hum Reprod 1993;8: 1055-1060.
10. Bonduelle M, Desmyttere S, Buysse A, Van Assche E, Schietecatte J, Devroey P, van Steirteghem AC, Liebaers I. Prospective follow-up study of 55 children born after subzonal insemination and intracytoplasmic sperm injection. Hum Reprod 1994;9:1765-1769.
11. Honig SC, Thompson S, Lipshultz LI. Reassessment of male-factor infertility, including the varicocele, sperm penetration assay, semen analysis, and in-vitro fertilization. Curr Opin Obstet Gynecol 1993;5:245-251.
12. Baker H. Clinical male infertility. 2. Critical evaluation of the prospects for therapy. Reprod Fertil Dev 1994;6:9-12.
13. Comhaire F, Zalata A, Mahmond A, Depoorter B, Huysse L, Christophe A, Depuydt C. Diagnostic and therapeutic approach to moderate and severe male subfertility in 1995. Hum Reprod 1995;10:144-150.
14. Silber SJ, Ord T, Balcameda J, Patrizio P, Asch RH. Congenital absence of vas deferens: the fertilizing capacity of human epididymal sperm. N Engl J Med 1990;323:1788-1792.
15. Belker AM, The Sperm Microaspiration Retrieval Techniques Study Group. Results in the United States with sperm microaspiration retrieval techniques and assisted reproductive technologies. J Urol 1994;151: 1255-1259.
16. Silber SJ, Nagy Z, Liu J, Godoy H, Devroey P, Van Steirteghem AL. Conventional in-vitro fertilization versus intracytoplasmic sperm injection for patients requiring microsurgical sperm aspiration. Hum Reprod 1994;9:1705-1709.
17. Ubaldi F, Liu J, Nagy Z, Tournaye H, Camus M, Van Steirteghem AC, Devroey P. Indications for and results of intracytoplasmic sperm injection (ICSI). Int J Androl 1995;18(suppl 2):88-90.
18. Silber SJ, Nagy Z, Liu J, Tournaye H, Lissens W, Devroey P, Van Steirteghem AC. The use of epididymal and testicular sperm for ICSI. J Assist Reprod Genet 1995;12:24S.
19. Silber SJ, Van Steirteghem AC, Liu J, Nagy Z, Tournaye H, Devroey P. High fertilization and pregnancy rate after intracytoplasmic sperm injection with spermatozoa obtained from testicular biopsy. Hum Reprod 1995;10:148-152.
20. Aiman J, Griffin JE, Gazale JM, Wilson JD, MacDonald PC. Androgen insensitivity as a cause of infertility in otherwise normal men. N Engl J Med 1979;300:223-227.
21. Aiman J, Griffin JE. The frequency of androgen receptor deficiency in infertile men. J Clin Endocrinol Metab 1982;54:725-732.
22. Bouchard P, Wright F, Portors MC, Couzinet B, Shaison G, Mowszowicz I. Androgen insensitivity in oligozoospermic men: a reprisal. J Clin Endocrinol Metab 1986;63:1242-1246.
23. Akin JA, Behzadian MA, Tho S, Mcdonough PG. Evidence for a partial deletion in the androgen receptor gene in a phenotypic male with azoospermia. Am J Obstet Gynecol 1991;165:1891-1893.
24. Van Roijen JH, Van Assen S, Van der Kwast TH, De Rooij DG, Boersma WJA, Vreeburg JTM, Weber RFA. Androgen receptor immunoexpression in the testes of subfertile men. J Androl 1995;16:510-516.
25. Namiki M, Koide T, Okuyama A, Sonoda T, Itatani H, Miyake A, Aono T, Terada N, Matsumoto K. Abnormality of testicular FSH receptors in infertile men. Acta Endocrinol 1984;106:548-555.
26. Nagafuchi S, Namiki M, Nakahori Y, Kondoh N, Okuyama A, Nakagome Y. A minute deletion of the Y chromosome in men with azoospermia. J Urol 1993;150:1155-1157.
27. Kobayashi K, Mizuno K, Hida A, Komaki R, Tomita K, Matsushita I, Namiki M, Iwamoto T, Tamura S, Minowada S, Nakahori Y, Nakagome Y. PCR analysis of the Y chromosome long arm in azoospermic patients: evidence for a second locus required for spermatogenesis. Hum Mol Genet 1994;3:1965-1967.
28. Mitchell MJ, Woods DR, Tucker PK, Opp JS, Bishop CE. Homology of a candidate spermatogenic gene from the mouse Y chromosome to the ubiquitin-activating enzyme E1. Nature 1991;354:483-486.
29. Kay GF, Ashworth A, Penny GD, Dunlop M, Swift S, Brockdorff N, Rastan S. A candidate spermatogenesis gene on the mouse Y chromosome is homologous to ubiquitin-activating enzyme E1. Nature 1991;354: 486-489.
30. Ma K, Sharkey A, Kirsch S, Vogt P, Hargreave TB, McBeath S, Chandley AC. Towards the molecular localisation of the AZF locus: mapping of micro-deletions in azoospermic men within 14 subintervals of interval 6 of the human Y chromosome. Hum Mol Genet 1992;1:29-33.
31. Ma K, Inglis JD, Sharkey A, Bickmore WA, Hill RE, Prosser EJ, Speed RM, Thomson EJ, Jobling M, Taylor K, Wolfe J, Cooke HJ, Hargreave TB, Chandley AC. AY chromosome gene family with RNA-binding protein homology: candidates for the azoospermia factor AZF controlling human spermatogenesis. Cell 1993;75:1287-1295.
32. Reijo R, Lee T-Y, Salo P, Alagappan R, Brown LG, Rosenberg M, Rosen S, Jaffe T, Straus D, Hovatta O, De la Chapelle A, Silber S, Page DC. Diverse spermatogenic defects in humans caused by Y chromosome deletions encompassing a novel RNA-binding protein gene. Nature Genet 1995;10:383-393.
33. Sharpe RM. Regulation of spermatogenesis. In: Knobil E, Neill JD (eds) The physiology of reproduction. 2nd ed. New York: Raven Press, 1994:1363-1434.
34. Furukawa K, Inagami H, Hotta Y. Identification and cloning of an mRNA coding for a germ cell-specific A-type lamin in mice. Exp Cell Res 1994;212:426-430.
35. Ohsako S, Hayashi Y, Bunick D. Molecular cloning and sequencing of calnexin-t: an abundant male germ cell-specific calcium-binding protein of the endoplasmic reticulum. J Biol Chem 1994;269:14140-14148.
36. Watanabe D, Yamada K, Nishina Y, Tajima Y, Koshimizu U, Nagata A, Nishimune Y. Molecular cloning of a novel Ca-binding protein (Calmegin) specifically expressed during male meiotic germ cell development. J Biol Chem 1994;269:7744-7749.
37. Slegtenhorst-Eegdeman KE, Post M, Baarends WM, Themmen APN, Grootegoed JA. Regulation of gene expression in Sertoli cells by follicle-stimulating hormone (FSH): cloning and characterization of LRPR1, a primary response gene encoding a leucine-rich protein. Mol Cell Endocrinol 1995;108:115-124.
38. Hendriksen PJM, Hoogerbrugge JW, Themmen APN, Koken MHM, Hoeijmakers JHJ, Oostra BA, Van der Lende T, Grootegoed JA. Post-meiotic transcription of X and Y chromosomal genes during spermatogenesis in the mouse. Dev Biol 1995;170:730-733.
39. Braun RE, Lee K, Schumacher JM, Fajardo MA. Molecular genetic analysis of mammalian spermatid differentiation. Rec Prog Horm Res 1995;50:275-286.
40. Grootegoed JA, Baarends WM, Hendriksen PJM, Hoogerbrugge JW, Slegtenhorst-Eegdeman KE, Themmen APN. Hum Reprod 1995;10(suppl 1):10-14.
41. Vogt PH. Genetic aspects of human infertility. Int J Androl 1995;18(suppl 2):3-6.
42. Hirose T, O'Brien DA, Jetten AM. RTR: a new member of the nuclear receptor superfamily that is highly expressed in murine testis. Gene 1995;152:247-251.
43. 17KB) highly expressed in rat testis. Biochem J 1995;305:125-132.
44. Glick BS. Can Hsp70 proteins act as force-generating motors? Cell 1995;80:11-14.
45. Billig H, Furuta I, Rivier C, Tapanainen J, Parvinen M, Hsueh AJW. Apoptosis in testis germ cells: developmental changes in gonadotropin dependence and localization to selective tubule stages. Endocrinology 1995;136:5-12.
46. Nantel F, Monaco L, Foulkes NS, Masquilier D, LeMeur M, Henriksen K, Dlerich A, Parvinen M, Sassone-Corsi P. Spermiogenesis deficiency and germ-cell apoptosis in CREM-mutant mice. Nature 1996;380:159-165.
47. Namiki M, Matsumiya K, Takada S, Kitamura M, Kondoh N, Uchida K, Park N-C, Kiyohara H, Okuyama A. The Acrobeads test for evaluation of sperm function: clinical application. Assist Reprod Technol Androl 1995;7:69-72.
48. Yanagimachi R. Penetration of guinea-pig spermatozoa into hamster eggs in vitro. J Reprod Fertil 1972; 28:477-480.
49. Yanagimachi R, Yanagimachi H, Rogers BJ. The use of zona-free animal ova as a test-system for the assessment of the fertilizing capacity of human spermatozoa. Biol Reprod 1976;15:471-476.
50. Yang YS, Rojas FJ, Stone SC. Acrosome reaction of human spermatozoa in zona-free hamster egg penetration test. Fertil Steril 1988;50:954-959.
51. Okabe M, Nagira M, Kawai Y. A human sperm antigen possibly involved in binding and/or fusion with zona-free hamster eggs. Fertil Steril 1990;54:1121-1126.
52. Ohashi K, Saji F, Kato M. Evaluation of acrosomal status using MH61-beads test and its clinical application. Fertil Steril 1992;58:803-808.
53. Hargreave TB. Non-specific treatment for male infertility. In: Hargreave TB (ed) Male infertility. 2nd ed. London: Springer-Verlag, 1994:393-409.
54. Burris AS, Redband HW, Winters SJ, Sherins RJ. Gonadotropin therapy in men with isolated hypogonadotropic hypogonadism: the response to human chorionic gonadotropin is predicted by initial testicular size. J Clin Endocrinol Metab 1983;66:1144-1151.
55. Finkel DM, Phillips JL, Snyder PJ. Stimulation of spermatogenesis by gonadotropins in men with hypogonadotropic hypogonadism. N Engl J Med 1985;313:651-655.
56. Ley SB, Leonard JM. Male hypogonadotropic-hypogonadism: factors influencing response to human chorionic gonadotropin and human menopausal gonadotropin, including prior exogenous androgens. J Clin Endocrinol Metab 1985;61:746-752.
57. Okuyama A, Nakamura M, Namiki M, Aono T, Matsumoto K, Sonoda T. Testicular responsiveness to long-term administration of hCG and hMG in patients with hypogonadotropic hypogonadism. Horm Res 1986;23:21-30.
58. Homonnai ZT, Peled M, Paz GF. Changes in semen quality and fertility in response to endocrine treatment of subfertile men. Gynecol Obstet Invest 1978;9:244-255.
59. Chehval MJ, Mehan DJ. Chorionic gonadotropins in the treatment of the subfertile male. Fertil Steril 1979;31:666-668.
60. Margalioth EJ, Laufer N, Persistz E, Gaulayev B, Shemesh A, Schenker JG. Treatment of oligoasthenospermia with human chorionic gonadotropin: hormonal profiles and results. Fertil Steril 1983;39:841-844.
61. Pusch HH, Purstner P, Haas J. Treatment of asthenozoospermia with HCG. Andrologia 1986; 18:201-207.
62. Knuth UA, Honigl W, Bals-Pratsch M, Schleicher G, Nieschlag E. Treatment of severe oligozoospermia with human chorionic gonadotrophin/human menopausal gonadotrophin: a placebo-controlled double-blind trial. J Clin Endocrinol Metab 1987;65:1081-1087.
63. Ross LS, Kandel GL, Prinz LM, Auletta F. Clomiphene treatment of the idiopathic hypofertile male: high-dose, alternate-day therapy. Fertil Steril 1980;33:618-623.
64. Wang C, Chan CW, Wong KK, Yeung KK. Comparison of the effectiveness of placebo, clomiphene citrate, mesterolone, pentoxifylline, and testosterone rebound therapy for the treatment of idiopathic oligospermia. Fertil Steril 1983;40:358-365.
65. Sokol RZ, Steiner BS, Bustillo M, Petersen G, Swerdloff RS. A controlled comparison of the efficacy of clomiphene citrate in male infertility. Fertil Steril 1988;49:865-870.
66. World Health Organization. A double-blind trial of clomiphene citrate for the treatment of idiopathic male infertility. Int J Androl 1992;15:299-307.
67. Schill WB. Treatment of idiopathic oligozoospermia by kallikrein: results of a double blind study. Arch Androl 1979;2:163-170.
68. Micic S, Bila S, Ilic V, Solovic S. Treatment of men with oligoasthenozoospermia and asthenozoospermia with kallikrein. Acta Eur Fertil 1985;16:51-53.
69. Harris WA, Harden TE, Dawson EB. Apparent effect of ascorbic acid medication on semen metal levels. Fertil Steril 1979;32:455-459.
70. Hargreave TB, Kyle KF, Baxby K, Rogers ACN, Scott R, Tolley DA, Abel BJ, Orr PS, Elton RA. Randomised trial of mesterolone versus vitamin C for male infertility. Br J Urol 1984;56:740-744.
71. Okuyama A, Namiki M, Sonoda T, Hayashi T. Effects of hachimijiohgan and ninjintoh on fertility in males with sterility. Acta Urol Jpn 1984;30:409-413.
72. Matsumiya K, Kitamura M, Koga M, Uchida K, Takada S, Kondoh N, Takeyama M, Fujiwara Y, Namiki M, Okuyama A. Clinical trial of nasal GnRH (Buserelin acetate) for the treatment of oligoasthenozoospermia. Jpn J Urol 1996;87:488.
73. Aitken JR, Clarkson JS. Cellular basis of defective sperm function and its association with the genesis of reactive oxygen species by human spermatozoa. J Reprod Fertil 1987;81:459-469.
74. Aitken JR, Irvine DS, Wu FC. Prospective analysis of sperm-oocyte fusion and reactive oxygen species generation as criteria for the diagnosis of infertility. Am J Obstet Gynecol 1991;164:542-551.
75. Iwasaki A, Gagnon C. Formation of reactive oxygen species in spermatozoa of infertile patients. Fertil Steril 1992;57:409-416.
76. Plante M, De Lamirande E, Gagnon C. Reactive oxygen species released by activated neutrophils, but not by deficient spermatozoa, are sufficient to affect normal sperm motility. Fertil Steril 1994;62:387-393.
77. De Lamirande E, Gagnon C. Impact of reactive oxygen species on spermatozoa: a balancing act between beneficial and detrimental effects. Hum Reprod 1995:10(suppl 1):15-21.
78. Alvarez JG, Touchstone JC, Blasco L, Storey BT. Spontaneous lipid peroxidation and production of hydrogen peroxide and Superoxide in human spermatozoa. Superoxide dismutase as major enzyme protectant against oxygen toxicity. J Androl 1987; 8:338-348.
79. Calvayrac R. Catalase activity in human spermatozoa and seminal plasma. Gamete Res 1989;24:185-196.
80. Alvarez JG, Storey BT. Role of glutathione peroxidase in protecting mammalian spermatozoa from loss of motility caused by spontaneous lipid peroxidation. Gamete Res 1989;23:77-90.
81. Park N-C, Namiki M, Takahashi K, Takada S, Kondoh N, Matsumiya K, Kiyohara H, Kosaka H, Sakoda S, Yoon J-B, Okuyama A. Relationship between reactive oxygen species and glutathione peroxidase in the seminal plasma of infertile men. Assist Reprod Technol Androl 1995;8:71-76.
82. Iwanier K, Zachara BA. Selenium supplementation enhances the element concentration in blood and seminal fluid but does not change the spermatozoal quality characteristics in subfertile men. J Androl 1995;16:441-447.
83. Aitken RJ, Clarkson JS. Significance of reactive oxygen species and antioxidants in defining the efficacy of sperm preparation techniques. J Androl 1988;9:367-376.
84. Dawson EB, Harris WA, Teter MC, Powell LC. Effect of ascorbic acid supplementation on the sperm quality of smokers. Fertil Steril 1992;58:1034-1039.
85. Dodson WC, Haney AF. Controlled ovarian hyperstimulation and intrauterine insemination for treatment of infertility. Fertil Steril 1991;55:457-467.
86. Cohlen BJ, te Velde ER, Van Kooij RJ. Is there still a place for male subfertility? A Review. Int J Androl 1995;18(suppl 2):72-75.
87. Comhaire F, Depypere H, Millingos S. Statement on intra-uterine insemination. Int J Androl 1995; 18(suppl 2):76-77.
88. Terquem A, Dadoune JP. Morphological findings in varicocele: an ultrastructural study of 30 bilateral testicular biopsies. Int J Androl 1981;4:515-531.
89. Haans LC, Laven JS, Mali WP, Te Velde ER, Wensing CJ. Testis volumes, semen quality, and hormonal patterns in adolescents with and without a varicocele. Fertil Steril 1991;56:731-736.
90. Amelar RD, Dubin L. Therapeutic implications of left, right, and bilateral varicocelectomy. Urology 1987;30:53-57.
91. Kondoh N, Meguro N, Matsumiya K, Namiki M, Kiyohara H, Okuyama A. Significance of subclinical varicocele detected by scrotal sonography in male infertility: a preliminary report. J Urol 1993;150:1158-1160.
92. Okuno H, Shichiri Y, Ohnishi H, Hashimura T, Yoshida O. Effectiveness of the treatment for subclinical right varicocele: a prospective randomized study. Jpn J Urol 1996;87:470.
93. Palomo A. Radical cure of varicocele by new technique: preliminary report. J Urol 1949;61:604-607.
94. Mehan DJ, Andrus CH, Parra RO. Laparoscopic internal spermatic vein ligation: report of a new technique. Fertil Steril 1992;58:1263-1266.
95. Costable RA, Howard SS. Surgical approach for the correction of varicocele. In: Thomas AJ Jr, Nagler HM (eds) Atlas of surgical management of male infertility. Tokyo: Igaku-Shoin, 1995:21-24.
96. Lima SS, Castro O. A new method for the treatment of varicocele. Andrologia 1978;10:103-106.
97. Belker AM, Thomas AJ Jr, Fuchs EF, Konnak JW, Sharlip ID. Results of 1,469 microsurgical vasectomy reversals by the Vasovasostomy Study Group. J Urol 1991;145:505-511.
98. Thomas AJ Jr. Vasoepididymostomy. In: Thomas AJ Jr, Nagler HM (eds) Atlas of surgical management of male infertility. Tokyo: Igaku-Shoin, 1995:62-70.
99. Rosen EG, Nagler HM. Ejaculatory duct obstruction. In: Thomas AJ Jr, Nagler HM (eds) Atlas of surgical management of male infertility. Tokyo: Igaku-Shoin, 1995:79-87.
100. Ubaldi F, Liu J, Nagy H, Tournaye H, Camus M, Van Steirteghem AV, Devroey P. Indications for and results of intracytoplasmic sperm injection (ICSI). Int J Androl 1995;18(suppl 2):88-90.
101. Bennett CJ, Ayers JWT, Randolph JF Jr, Seager SWJ, McCabe M, Moinipanah R. Electroejaculation of paraplegic males followed by pregnancies. Fertil Steril 1987;48:1070-1072.
102. Te Velde ER, Habbema JDF, Van Kooij RJ. Application of in-vitro fertilization in (almost) fertile couples should, and can, be avoided. Int J Androl 1995; 18(suppl 2):91-93.
103. Comhaire F. Economic strategies in modern male subfertility treatment. Hum Reprod 1995;10(suppl 1): 103-106.
104. Comhaire F, Milingos A, Liapi A, Campo R, Depypere H, Dhont M, Schoonjans F. The effective cumulative pregnancy rate of different modes of treatment of male infertility. Andrologia 1995;27: 217-221.